MINDERA
DEAD

Serial Number

90305558

Owner

MINDERA Corporation

Attorney

Johnny F. Manriquez

Filing Date

Nov 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MINDERA Trademark

Serial Number: 90305558

MINDERA is a trademark filed by MINDERA Corporation on November 8, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

MINDERA Corporation (11 trademarks)

329 Oyster Point Blvd, Third Floor
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

November 8, 2020

Registration Date

Not Registered

Goods & Services

Medical services; Nucleic acid sequencing and analysis services for medical purposes; Genome sequencing and analysis services for medical purposes; Medical genetic analysis and reporting services for diagnostic, prognostic or treatment uses; Medical testing and analysis for diagnostic and treatment purposes; DNA, RNA, nucleic acid and genetic sequencing, screening, and analysis services for medical purposes; Clinical diagnostic and consultation services for medical purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine

Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 10, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 10, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 21, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 21, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 21, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 9, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2021 NWOS
NEW APPLICATION ENTERED
Nov 11, 2020 NWAP